The Subtle Harms of Psychedelic-Assisted Therapy and Facilitation (Part 2)
Psychedelic therapy, due to the combination of heightened suggestibility, powerful altered states, and unique power imbalances, opens the door to undue influence of the kind not seen in ordinary psychotherapy. The post The Subtle Harms of Psychedelic-Assisted Therapy and Facilitation (Part 2) appeared first on Chemical Collective.
External link. We are not responsible for the content.
Read more ↗More From Chemical Collective
The Subtle Harms of Psychedelic-Assisted Therapy and Facilitation (Part 1)
Despite its cultural prestige and rapid commercial growth, psychotherapy – as well as psychedelic-assisted therapy – ...
LSD, Music, and the Art of Listening
Oli Genn-Bash discusses how LSD uniquely enhances active listening, creativity, and musical insight, offering a more ...
Psychedelics and Compassion Overload
Psychedelic experiences can enhance empathy and compassion in ways that support mental health and therapeutic outcome...
Latest News
AtaiBeckley Seeks Partner for BPL-003 as Pharma Interest Builds After AbbVie-Gilgamesh Deal
AtaiBeckley is in structured discussions with pharma companies and royalty investors about a potential partnership fo...
Psilocybin Isn’t Legal Yet. So, Why Are States Writing Laws for It?
PLUS ketamine spoons, sleep tripping, and psilocybin vs. anti-depressants. [...] Read More... The post Psilocybin Isn...
The Therapeutic Potential of Psychedelics in the Treatment of Substance Use Disorders
Substance use disorders (SUDs) remain among the most persistent global public health challenges. Despite decades of p...
A new “magic mushroom” drug could treat depression without psychedelic hallucinations
Scientists are exploring a new way to harness the medical promise of psychedelic compounds without the mind-bending s...
AtaiBeckley’s MDMA product could treat social anxiety; HHS Secretary Kennedy talks psychedelics on Rogan podcast; WV Senate and SD legislature pass Compass trigger bills
Plus: Pilot study uses psilocybin for post-treatment Lyme disease and Psychedelic-assisted therapy bill rejected then...
Pα+ February 2026 Psychedelic Bill Roundup
A state-by-state and federal review of psychedelics-related bills introduced or advanced in February 2026, including ...